Glycaemic outcomes in people with type 2 diabetes initiating continuous glucose monitoring: The 2GO-CGM study
- Conditions
- Type 2 diabetesMetabolic and Endocrine - Diabetes
- Registration Number
- ACTRN12621000889853
- Lead Sponsor
- niversity of Otago
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 71
1.Type 2 diabetes as per ADA classification
2.HbA1c greater than 8.0%
3.Minimum daily insulin requirement of greater than or equal to 0.2 units insulin/kg/day, for at least 3 months previous to study enrollment.
4.Aged 16 years and over.
5.Be willing and able to conform to the study protocol
1.History of Type 1 diabetes
2.History of other types of diabetes such as MODY, secondary pancreatic diabetes, diabetes due to endocrinopathies
3.Has had a hospital admission for hyperglycaemia in last 6 months
4.Use of systemic corticosteroids for more than 14 days, or repeated pharmacologic systemic courses of corticosteroids
5.Recurrent or chronic systemic infections that in the view of the investigator would significantly impact on glycaemia.
6.Major cardiovascular event (including or not limited to MI, CVA, CABG, PTCA) or major surgery in last 3 months
7.Active malignancy requiring ongoing treatment
8.Previous or planned bariatric surgery.
9.Pregnancy
10.Any other reason that investigator feels may not be in best interest of patient to participate.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method